PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 135 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,888,000 | -86.2% | 365,100 | -6.6% | 1.16% | -83.5% |
| Q1 2022 | $20,980,000 | +77.3% | 391,000 | +13.0% | 7.02% | +115.2% |
| Q4 2021 | $11,833,000 | +93.0% | 346,000 | 0.0% | 3.26% | +102.9% |
| Q3 2021 | $6,131,000 | -51.6% | 346,000 | +22.5% | 1.61% | -45.3% |
| Q2 2021 | $12,676,000 | +105.3% | 282,445 | +18.5% | 2.94% | +71.5% |
| Q1 2021 | $6,173,000 | +64.7% | 238,354 | +28.2% | 1.71% | +22.5% |
| Q4 2020 | $3,747,000 | – | 185,854 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |